Sasha Keough
Sr One Capital Management, Lp
Assets Managed
$915.442M
Holdings
14
Last Quarter
2026 - Q1
Filed Date
10d ago
Growth Rate
29.6%(2Q avg: 15.89%)
Sustained Growth
4 quarters
Portfolio positions
This chart displays the top 10 holdings in Sr One Capital Management, Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 14 positions.
Assets under management
The assets under management (AUM) of Sr One Capital Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 915.442M in assets, with a quarterly growth rate of 29.6% and a 2-quarter average growth rate of 15.89%. The portfolio is managed by Sasha Keough, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
ACLX Arcellx Inc
| 29.44% | $269.44M 2.347M shares@ $114.83 avg price | |
MANE Veradermics Inc
| 16.57% | $151.678M 2.402M shares@ $63.15 avg price | New Position |
ZBIO Zenas Biopharma Inc
| 10.76% | $98.49M 5.038M shares@ $19.56 avg price | |
CRSP Crispr Therapeutics Ag
| 10.6% | $96.984M 2.039M shares@ $47.58 avg price | |
DSGN Design Therapeutics Inc
| 7.59% | $69.442M 6.526M shares@ $10.64 avg price | |
ORIC Oric Pharmaceuticals Inc
| 6.39% | $58.477M 4.515M shares@ $12.96 avg price | |
ALMS Alumis Inc
| 4.72% | $43.177M 1.96M shares@ $22.04 avg price | |
MLYS Mineralys Therapeutics Inc
| 4.63% | $42.368M 1.564M shares@ $27.1 avg price | |
SPRY Ars Pharmaceuticals Inc
| 3.53% | $32.224M 4.013M shares@ $8.03 avg price | |
ORKA Oruka Therapeutics Inc
| 2.31% | $21.108M 430,330 shares@ $49.05 avg price |
1-10 of 14